Literature DB >> 18648918

Pleiotropic effects of neurotransmission during development: modulators of modularity.

Barbara L Thompson1, Gregg D Stanwood.   

Abstract

The formation and function of the mammalian cerebral cortex relies on the complex interplay of a variety of genetic and environmental factors through protracted periods of gestational and postnatal development. Biogenic amine systems are important neuromodulators, both in the adult nervous system, and during critical epochs of brain development. Abnormalities in developmental programming likely contribute to developmental delays and multiple neurological and psychiatric disorders, often with symptom onset much later than the actual induction of pathology. We review several genetic and pharmacological models of dopamine, norepinephrine and serotonin modulation during development, each of which produces permanent changes in cerebral cortical structure and function. These models clearly illustrate the ability of these neurotransmitters to function beyond their classic roles and show their involvement in the development and modulation of fine brain circuitry that is sensitive to numerous effectors. Furthermore, these studies demonstrate the need to consider not only gene by environment interactions, but also gene by environment by developmental time interactions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18648918      PMCID: PMC2777884          DOI: 10.1007/s10803-008-0624-0

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  108 in total

Review 1.  Cortex, cognition and the cell: new insights into the pyramidal neuron and prefrontal function.

Authors:  Guy N Elston
Journal:  Cereb Cortex       Date:  2003-11       Impact factor: 5.357

Review 2.  The neuropsychology of ventral prefrontal cortex: decision-making and reversal learning.

Authors:  L Clark; R Cools; T W Robbins
Journal:  Brain Cogn       Date:  2004-06       Impact factor: 2.310

Review 3.  Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development.

Authors:  Gregg D Stanwood; Pat Levitt
Journal:  Curr Opin Pharmacol       Date:  2004-02       Impact factor: 5.547

4.  Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background.

Authors:  A Holmes; Q Lit; D L Murphy; E Gold; J N Crawley
Journal:  Genes Brain Behav       Date:  2003-12       Impact factor: 3.449

Review 5.  Cocaine effects on the developing brain: current status.

Authors:  John A Harvey
Journal:  Neurosci Biobehav Rev       Date:  2004-01       Impact factor: 8.989

Review 6.  Consequences of prenatal cocaine exposure in nonhuman primates.

Authors:  Michael S Lidow
Journal:  Brain Res Dev Brain Res       Date:  2003-12-30

7.  Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex.

Authors:  Melissa C Rhodes; Frederic J Seidler; Ali Abdel-Rahman; Charlotte A Tate; Abraham Nyska; Heather L Rincavage; Theodore A Slotkin
Journal:  J Pharmacol Exp Ther       Date:  2003-11-10       Impact factor: 4.030

Review 8.  Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders.

Authors:  Pat Levitt; Kathie L Eagleson; Elizabeth M Powell
Journal:  Trends Neurosci       Date:  2004-07       Impact factor: 13.837

9.  Repeated i.v. cocaine exposure produces long-lasting behavioral sensitization in pregnant adults, but behavioral tolerance in their offspring.

Authors:  G D Stanwood; P Levitt
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Cognitive outcomes of preschool children with prenatal cocaine exposure.

Authors:  Lynn T Singer; Sonia Minnes; Elizabeth Short; Robert Arendt; Kathleen Farkas; Barbara Lewis; Nancy Klein; Sandra Russ; Meeyoung O Min; H Lester Kirchner
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

View more
  7 in total

1.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

2.  Altered cerebellar organization and function in monoamine oxidase A hypomorphic mice.

Authors:  Loai Alzghoul; Marco Bortolato; Foteini Delis; Panayotis K Thanos; Ryan D Darling; Sean C Godar; Junlin Zhang; Samuel Grant; Gene-Jack Wang; Kimberly L Simpson; Kevin Chen; Nora D Volkow; Rick C S Lin; Jean C Shih
Journal:  Neuropharmacology       Date:  2012-08-16       Impact factor: 5.250

3.  Description and validation of a dynamical systems model of presynaptic serotonin function: genetic variation, brain activation and impulsivity.

Authors:  Scott F Stoltenberg; Parthasarathi Nag
Journal:  Behav Genet       Date:  2010-01-29       Impact factor: 2.805

4.  Loss of Thr286 phosphorylation disrupts synaptic CaMKIIα targeting, NMDAR activity and behavior in pre-adolescent mice.

Authors:  Richard M Gustin; Brian C Shonesy; Stacey L Robinson; Tyler J Rentz; Anthony J Baucum; Nidhi Jalan-Sakrikar; Danny G Winder; Gregg D Stanwood; Roger J Colbran
Journal:  Mol Cell Neurosci       Date:  2011-05-24       Impact factor: 4.314

5.  ttime: an R package for translating the timing of brain development across mammalian species.

Authors:  Radhakrishnan Nagarajan; Richard B Darlington; Barbara L Finlay; Barbara Clancy
Journal:  Neuroinformatics       Date:  2010-10

6.  Behavioral and Neuroanatomical Consequences of Cell-Type Specific Loss of Dopamine D2 Receptors in the Mouse Cerebral Cortex.

Authors:  Gloria S Lee; Devon L Graham; Brenda L Noble; Taylor S Trammell; Deirdre M McCarthy; Lisa R Anderson; Marcelo Rubinstein; Pradeep G Bhide; Gregg D Stanwood
Journal:  Front Behav Neurosci       Date:  2022-01-13       Impact factor: 3.558

7.  Developmentally Sensitive Interaction Effects of Genes and the Social Environment on Total and Subcortical Brain Volumes.

Authors:  Jennifer S Richards; Alejandro Arias Vásquez; Barbara Franke; Pieter J Hoekstra; Dirk J Heslenfeld; Jaap Oosterlaan; Stephen V Faraone; Jan K Buitelaar; Catharina A Hartman
Journal:  PLoS One       Date:  2016-05-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.